T. Sargent

649 total citations
21 papers, 421 citations indexed

About

T. Sargent is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, T. Sargent has authored 21 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Molecular Biology and 3 papers in Pharmaceutical Science. Recurrent topics in T. Sargent's work include Medical Imaging Techniques and Applications (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). T. Sargent is often cited by papers focused on Medical Imaging Techniques and Applications (7 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Amino Acid Enzymes and Metabolism (3 papers). T. Sargent collaborates with scholars based in United States and Chile. T. Sargent's co-authors include Alexander T. Shulgin, H. S. Winchell, Chester A. Mathis, Rashid A. Fawwaz, Myron Pollycove, Hiroshi Saito, Manuel C. Lagunas-Solar, Stephen M. Stahl, Juan M. Saavedra and Dennis J. McKenna and has published in prestigious journals such as Blood, European Journal of Pharmacology and American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.

In The Last Decade

T. Sargent

20 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Sargent United States 14 98 92 80 67 60 21 421
Thornton Sargent United States 11 115 1.2× 44 0.5× 101 1.3× 91 1.4× 17 0.3× 18 416
Susan Nielsen United States 10 152 1.6× 24 0.3× 22 0.3× 247 3.7× 73 1.2× 27 754
Scott W. Cummings United States 8 46 0.5× 8 0.1× 28 0.3× 175 2.6× 30 0.5× 12 499
G Sticht Germany 14 46 0.5× 15 0.2× 72 0.9× 367 5.5× 5 0.1× 54 715
Charles Masaki United States 9 43 0.4× 29 0.3× 22 0.3× 38 0.6× 9 0.1× 14 314
Jay J. Rubin United States 8 135 1.4× 8 0.1× 12 0.1× 112 1.7× 8 0.1× 9 455
J.A. Huff United States 8 124 1.3× 9 0.1× 11 0.1× 119 1.8× 9 0.1× 10 484
Douglas A. Peterson United States 14 27 0.3× 16 0.2× 14 0.2× 302 4.5× 40 0.7× 36 669
Jung‐Hui Sun United States 7 149 1.5× 12 0.1× 29 0.4× 199 3.0× 46 0.8× 12 664
R. Cantineau Belgium 15 114 1.2× 296 3.2× 15 0.2× 134 2.0× 30 585

Countries citing papers authored by T. Sargent

Since Specialization
Citations

This map shows the geographic impact of T. Sargent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Sargent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Sargent more than expected).

Fields of papers citing papers by T. Sargent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Sargent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Sargent. The network helps show where T. Sargent may publish in the future.

Co-authorship network of co-authors of T. Sargent

This figure shows the co-authorship network connecting the top 25 collaborators of T. Sargent. A scholar is included among the top collaborators of T. Sargent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Sargent. T. Sargent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McKenna, Dennis J., Chester A. Mathis, Alexander T. Shulgin, T. Sargent, & Juan M. Saavedra. (1987). Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain. European Journal of Pharmacology. 137(2-3). 289–290. 28 indexed citations
2.
Mathis, Chester A., Alexander T. Shulgin, Y. Yano, & T. Sargent. (1986). 18F-labelled N,N-dimethylamphetamine analogues for brain imaging studies. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 37(8). 865–872. 1 indexed citations
3.
Mathis, Chester A., et al.. (1986). A 122Xe122I generator for remote radio-iodinations. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 37(3). 258–260. 16 indexed citations
4.
Mathis, Chester A., T. Sargent, & Alexander T. Shulgin. (1985). Iodine-122-labeled amphetamine derivative with potential for PET brain blood-flow studies.. PubMed. 26(11). 1295–301. 13 indexed citations
5.
Mathis, Chester A., et al.. (1985). Synthesis and evaluation of meta-substituted I-122-labeled dimethoxy-N, N-dimethylamphetamines for brain imaging studies. 26(5). 69. 19 indexed citations
6.
Jernigan, Terry L., et al.. (1985). 18Fluorodeoxyglucose PET in schizophrenia. Psychiatry Research. 16(4). 317–329. 31 indexed citations
7.
Sargent, T., et al.. (1983). Kinetics of trace element chromium(III) in the human body. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 244(4). R445–R454. 54 indexed citations
8.
Sargent, T., et al.. (1978). Altered metabolism of the methionine methyl group in the leukocytes of patients with schizophrenia.. PubMed. 13(6). 649–60. 13 indexed citations
9.
Sargent, T., Thomas F. Budinger, Gerald S. Braun, Alexander T. Shulgin, & U. Braun. (1978). Iodinated catecholamine congener for brain imaging and metabolic studies. [/sup 123/I, /sup 131/I, dogs, monkeys]. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations
10.
Sargent, T., et al.. (1978). Brain and retina uptake of a radio-iodine labeled psychotomimetic in dog and monkey.. PubMed. 2(1). 1–10.
11.
Sargent, T., et al.. (1976). Quantitative measurement of demethylation of 14C-methoxyl labeled DMPEA and TMA-2 in rats.. PubMed. 2(3). 199–206. 4 indexed citations
12.
Sargent, T., et al.. (1975). In vivo human pharmacodynamics of the psychodysleptic 4-Br-2,5-dimethoxyphenylisopropylamine labelled with 82Br or 77Br. Neuropharmacology. 14(3). 165–174. 32 indexed citations
13.
Sargent, T., et al.. (1975). A potential new brain-scanning agent: 4-77Br-2,5-dimethoxyphenylisoproplamine (4-Br-DPIA).. PubMed. 16(3). 243–5. 20 indexed citations
14.
Shulgin, Alexander T., et al.. (1973). Animal Pharmacology and Human Psychopharmacology of 3-Methoxy-4,5-Methylenedioxyphenylisopropylamine (MMDA). Pharmacology. 10(1). 12–18. 9 indexed citations
15.
Shulgin, Alexander T., et al.. (1971). 4-Bromo-2,5-Dimethoxyphenylisopropylamine, a New Centrally Active Amphetamine Analog. Pharmacology. 5(2). 103–107. 38 indexed citations
16.
Winchell, H. S., et al.. (1971). Localization of polypeptide caseidin in the renal cortex: a new radioisotope carrier for renal studies.. PubMed. 12(10). 678–82. 12 indexed citations
17.
Sargent, T., Hiroshi Saito, & H. S. Winchell. (1971). Iron absorption in hemochromatosis before and after phlebotomy therapy.. PubMed. 12(10). 660–7. 20 indexed citations
18.
Fawwaz, Rashid A., et al.. (1970). Effect of phlebotomy and pH on iron absorption from the colon.. PubMed. 11(1). 25–7. 15 indexed citations
19.
Fawwaz, Rashid A., H. S. Winchell, Myron Pollycove, & T. Sargent. (1967). Hepatic Iron Deposition in Humans. Blood. 30(4). 417–424. 39 indexed citations
20.
Shulgin, Alexander T., et al.. (1967). Evaluation of 3,4-Methylenedioxyamphetamine (MDA) as an Adjunct to Psychotherapy. Pharmacology. 17(4). 359–364. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026